Connect with us

featured

Alabama Governor Faces Contrasting Calls To Sign Or Veto Hemp Regulation Bill On Her Desk

Published

on


“We’re just trying to figure out what exactly is going to happen and what is not going to happen before we really start doing anything.”

By Alander Rocha, Alabama Reflector

A bill aimed at regulating consumable hemp products has landed on Gov. Kay Ivey’s (R) desk, but its future is uncertain.

HB 445, sponsored by Rep. Andy Whitt (R-Harvest), would establish regulations for consumable hemp products in Alabama, but the bill’s language and potential consequences have led the hemp industry to suggest the possibility of litigation and led to uncertainty among lawmakers, business owners, patients and lobbyists.

“It is my hope that the governor signs the bill this week. I think it’s a good piece of legislation. I think it’s a bipartisan piece of legislation, and certainly, we have to get the guardrails up on this industry,” Whitt said in a phone interview Tuesday.

Key provisions of the bill include:

  • Testing and labeling requirements for all consumable hemp products.
  • Caps of 10 milligrams per individually wrapped product, with a cap of 40 milligrams per package.
  • Authorization for the Alcoholic Beverage Control (ABC) Board to license retailers of these products.
  • Restrictions on retail establishments selling hemp products.
  • Prohibition of sales to minors.
  • Prohibition of smokable hemp products and restrictions on online sales and direct delivery.
  • Imposition of an excise tax on consumable hemp products.

The bill defines “consumable hemp product” broadly as any finished product intended for human or animal consumption that contains any part of the hemp plant or its derivatives, but explicitly bans smokable hemp products and certain psychoactive cannabinoids.

It’s unclear whether the bill would ban CBD, a non-psychoactive cannabinoid found in hemp. According to the bill, “any smokeable hemp product” not limited to “plant product or raw hemp material that is marketed to consumers as hemp cigarettes, hemp cigars, hemp joints, hemp buds, hemp flowers, hemp leaves, ground hemp flowers, or any variation of these terms to include any product that contains a cannabinoid, whether psychoactive or not.”

Disagreement among lawmakers

The bill was replaced with a substitute on the floor that had not been discussed in the Senate committee hearing, and a copy was not made available to the public until after its passage. Molly Cole, a lobbyist for the Alabama Hemp and Vape Association, said she wished a senator had asked for the bill to be read on the floor.

“When Sen. Melson came onto the floor and proposed this bill for the substitute,…no one called for it to be read on the floor. And then the way he proposed it was that all this bill does is move products to 21 and up stores,” Cole said, which she felt was misleading.

Even the bill’s sponsor and the senator who handled the bill in the upper chamber appear to be at odds over its implementation.

Sen. Tim Melson (R-Florence), whose bill aimed at hemp regulation failed in committee but who handled Whitt’s legislation in the Senate, said in an interview Tuesday that he was uncertain about whether the bill bans hemp-derived THC vapes. He thought that hemp-derived vapes could still be purchased in a 21-plus vape shop.

“The hemp vape products, yes, anything with the THC would go to, my understanding…they would go to vape stores. But that being said, I’d have to double check now that you got me questioning,” Melson said.

Whitt, however, was clear on the matter.

“Any smokeable, any inhaleable product, is banned under this legislation. Vapes would be banned as well that had delta-8 and [delta]-9 in those,” he said.

Delta-8 THC and delta-9 THC are psychoactive compounds found in cannabis, according to the U.S. Food and Drug Administration (FDA).

‘Our future in Alabama is uncertain’

Representatives of the hemp industry strongly oppose the measure, warning of consequences for both businesses and consumers.

Carmelo Parasiliti, founder and CEO of Green Acres Organic Pharms in Florence, pointed to the potential damage the bill could have on his business. Parasiliti said that nearly every product they currently offer is federally legal and lab tested. Under HB 445, he said, it would all be illegal.

“We’re going to keep our storefront open and serve Alabama to the best of our ability, but our future in Alabama is uncertain, and I’m really hoping Gov. Kay Ivey will veto this bill if she truly supports small businesses,” Parasiliti said in an interview Tuesday.

He also pointed to potential harm to people who benefit from hemp medically, particularly those in a cancer program he started to provide free or low-cost hemp-derived products to people referred by providers.

“Even more troubling is the bill makes it unlawful to give these products away to people in need, no matter their condition, which I think is cruelty,” Parasiliti said.

Nancy Owen Nelson, a cancer patient living in Florence who uses hemp, mostly CBD, for symptom management and a participant in the Green Acres Organic Pharm cancer program, said she was disappointed with the bill. Nelson said he plans to write a letter to Ivey encouraging her to veto it. She said she tried to leave a voicemail but found it was full.

“The thing about this condition is that it is not anywhere in particular, so it is a whole body sensation, and a whole body fatigue. It helps me sleep, it helps me rest, and it helps me feel calmer,” Owen Nelson said.

Whitt and Melson say that the bill’s primary objective is to protect children and regulate an industry that has operated largely unchecked. Owen Nelson said she agrees with regulating the hemp industry but feels the bill goes too far, and that she wasn’t sure if the bill would accomplish its intent of limiting access for minors, saying that children will find a way to these products.

“It’s the responsibility of the vendors to not sell children and the families to protect their children within their homes,” she said.


Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.


Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Whitt felt strongly that the need for “guardrails” on the hemp industry, saying it was his goal to rein in “the wild west of what’s been derived out of the 2018 Farm Bill.”

The 2018 Farm Bill removed hemp and any cannabis product with no more than 0.3 percent THC by dry weight from the definition of marijuana under federal law.

Confusion in the industry

Molly Cole, a lobbyist for the Alabama Hemp and Vape Association, said the industry is confused about how the bill defines consumable hemp product. She also pointed to conflicting implementation dates, which say that the “act shall become effective on July 1, 2025,” but indicate that businesses have until January 1, 2026, to comply.

“That’s causing a lot of chaos and confusion,” she said.

The hemp industry is urging Ivey to veto HB 445. Gina Maiola, a spokeswoman for the governor, did not respond to a request for comment. If the governor vetoes the bill, the Legislature could override her veto, but it’s also unclear whether the Legislature has the votes. The bill passed with a 60–27 vote and 14 abstentions out of the House and a 19–13 vote in the Senate.

Parasiliti said he is hopeful for a veto.

“The governor’s office just celebrated last week small business week, and here we are,” he said. “If this bill is signed and put into law, it’s going to be putting a lot of small businesses out of business.”

Cole said that litigation is being considered, saying that “the entire industry is looking at best practices moving forward, and litigation is being contemplated.”

“We’re just trying to figure out what exactly is going to happen and what is not going to happen before we really start doing anything, but we are discussing it,” she said.

The Alabama Policy Institute, a conservative think tank, also came out against the bill, though for different reasons, claiming on X, formerly known as Twitter, that the bill would legalize recreational cannabis use “under the guise of protecting children.”

Adding to the opposition, Birmingham Mayor Randall Woodfin posted a statement on Facebook saying the bill undermines progress made in cannabis reform and harms small businesses.

“Alabama House Bill 445 is a step backwards and harmful to small businesses in Birmingham,” Woodfin said. “Instead of moving us closer to justice and equity, this bill risks dragging us back to an era of cannabis criminalization, overregulation, and lost opportunity.”

This story was first published by Alabama Reflector.

Pennsylvania Governor Will Put Marijuana Legalization In His Budget, But Top GOP Senator Remains Skeptical

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!





Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

featured

Senate Votes To Let VA Doctors Recommend Medical Marijuana To Military Veterans, While Setting Aside Hemp THC Ban

Published

on


The Senate has approved large-scale spending legislation that includes provisions to allow U.S. Department of Veterans Affairs (VA) doctors to recommend medical marijuana to military veterans living in legal states.

The appropriations package that senators passed on Friday was also amended to omit a controversial proposed ban consumable hemp products with any quantifiable amount of THC.

After being cleared by the Senate Appropriations Committee last month, the full chamber advanced the package covering Military Construction, Veterans Affairs (MilConVA) and Agriculture, Rural Development, Food and Drug Administration (AgFDA) in a 87-9 vote.

In committee, members adopted an amendment to the MilConVA measure from Sen. Jeff Merkley (D-OR) that contains the cannabis and veterans language. For AgFDA, the bill initially featured hemp language that stakeholders argued would devastate the industry, but an agreed-upon amendment removed those provisions following tense deliberations.

The Merkley amendment attached to the underlying defense appropriations measure is meant to mirror standalone legislation titled the Veterans Equal Access Act. The text of the proposal adopted by the Senate committee is not identical to what the House passed as part of its own MilConVA appropriations measure in June.

On the House side, Reps. Brian Mast (R-FL) and Dave Joyce (R-OH)—who are both co-chairs of the Congressional Cannabis Caucus—sponsored the adopted companion amendment, which would increase veterans’ access to state medical marijuana programs and eliminate a current VA directive barring the department’s doctors from issuing cannabis recommendations.

Mast in February filed the standalone Veterans Equal Access Act—marking one of the latest attempt to enact the measure that’s enjoyed bipartisan support over recent sessions.

In past years, both the House and Senate have included provisions in their respective MilConVA measures that would permit VA doctors to make the medical cannabis recommendations, but they have never been enacted into law.

Because both chambers again adopted differing language this year, the matter will once more be a topic of conversation in conference committee or informal bicameral negotiations and, as such, could end up being left out of the final package sent to the president this time, as has been the case in the past.

Here’s the text of the House version: 

“None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used to enforce Veterans Health Directive 1315 as it relates to—

(1) the policy stating that ‘VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program’;

(2) the directive for the ‘Deputy Under Secretary for Health for Operations and Management’ to ensure that ‘medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs’; and

(3) the directive for the ‘VA Medical Facility Director’ to ensure that ‘VA facility staff are aware of the following’ ‘[t]he prohibition recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs’.”

The Senate language reads:

“None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used in a manner that would—

(1) interfere with the ability of a veteran to participate in a medicinal marijuana program approved by a State;

(2) deny any services from the Department to a veteran who is participating in such a program; or

(3) limit or interfere with the ability of a health care provider of the Department to make appropriate recommendations, fill out forms, or take steps to comply with such a program.”

Also attached to the MilConVA bill that the Senate approved is a report that contains cannabis and psychedelics provisions, including a call to allow VA doctors to recommend medical cannabis if the federal government reschedules it.

If rescheduling does happen, “VA should consider issuing guidance allowing VHA doctors and other personnel to discuss, recommend, and facilitate access to medical marijuana in States with state-legal medical marijuana programs to the extent allowable under Federal law,” the report says.

Another section discusses the potential for cannabis to be used as an alternative treatment option for veterans, urging VA to study “the relationship between treatment programs involving medical marijuana that are approved by States, the access of veterans to such programs, and a reduction in opioid use and abuse among veterans.”

Additionally, a section of the report for MilConVA addresses psychedelics-assisted therapy, noting that members understand “VA and other relevant Federal agencies are undertaking research to evaluate the efficacy of psychedelic-assisted therapies in treating PTSD, major depressive disorder, and other conditions.”

The committee is mandating that VA produce a report to Congress that lays out the status of research into the topic within 180 days of the bill’s enactment, and it’s further directing the agency to “initiate a longitudinal study of veterans participating in such therapies and track outcomes over a period of five years.”

The report further discusses GI Bill benefits as they related to cannabis, noting that “VA policy determinations have restricted the ability of veterans to access their earned benefits, including GI Bill Benefits.”

Under the AgFDA appropriations measure that the Senate also passed as part of a package on Friday, there are no longer provisions hemp industry stakeholders said would effectively eradicate the market by banning consumable hemp products with any “quantifiable” amount of THC.

Sen. Mitch McConnell (R-KY), who ushered in the federal legalization of hemp under the 2018 Farm Bill, championed the THC criminalization language. But while he got it included in the base bill for Ag/FDA, Sen. Rand Paul (R-KY) threatened to procedurally hold up the process if it stayed in, forcing McConnell’s hand. Paul’s amendment to strike the language passed as part of an en bloc package on the floor on Friday.

That came after a verbal lashing from McConnell, who took to the floor earlier in the day to criticize those who opposed the ban, including Paul.

“In order to move the package forward, I allowed my language to be stripped from the bill,” McConnell said. “But my effort to root out bad actors, protect our children, support farmers and reaffirm our original legislative intent will continue.”

The hemp language in the Senate spending bill was nearly identical to what the House Appropriations Committee passed in June, with noted cannabis prohibitionist Rep. Andy Harris (R-MD) leading the charge.

Meanwhile, Paul recently filed a standalone bill that would go in the opposite direction of the hemp ban, proposing to triple the concentration of THC that the crop could legally contain, while addressing multiple other concerns the industry has expressed about federal regulations.

The senator introduced the legislation, titled the Hemp Economic Mobilization Plan (HEMP) Act, in June. It mirrors versions he’s sponsored over the last several sessions.


Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.


Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Meanwhile, a GOP-controlled House committee last month approved an amendment attached to a must-pass defense bill that would require a “progress report” on an ongoing psychedelic therapy pilot program for active duty military service members and veterans.

However, while Congress has been notably amenable to psychedelics research proposals in recent sessions, the House Rules Committee separately blocked a bipartisan amendment to a spending bill led by Rep. Morgan Luttrell (R-TX) that would have given DOD another $10 million to support clinical trials into the therapeutic potential of substances such as ibogaine and psilocybin.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

Japanese Study Busts the ‘Gateway Drug’ Myth, With Gov’t Support

Published

on


“Cannabis is dangerous.” “Weed leads you to other drugs.” “Marijuana opens the door to harder substances.”

How many times have we heard these claims, without clear support or solid scientific evidence behind them? Too many to count, right? Now, a study backed by the Japanese government itself is using hard data to dismantle one of the most persistent theories in prohibitionist discourse: the gateway drug hypothesis, as shared by Marijuana Moment.

In January 2021, the Japanese Clinical Association of Cannabinoids, with support from the Japanese Ministry of Health, Labor and Welfare, conducted an anonymous survey of 3,900 people who had used cannabis at some point in their lives.

After an extensive analysis and review process, the results were published this month in the journal Neuropsychopharmacology Reports, marking a turning point in the scientific and political approach to cannabis in the country.

Booze, Smokes… Then the Bud

One of the most compelling findings is that cannabis is not actually the gateway drug to substance use. In fact, in most cases, it was the third substance used, after alcohol and tobacco: two legal drugs, widely socially accepted that, paradoxically, have the highest documented rates of harm.

The study reveals that almost half of the respondents who reported cannabis as their third drug did not subsequently use any other substance. The odds of marijuana users progressing to other substances were actually low:

  • 1.25 for alcohol
  • 0.77 for tobacco
  • 0.08 for methamphetamine
  • 0.78 for other illicit drugs

What If It’s Not Cannabis, But the World Around It?

Rather than a causal relationship between cannabis and problematic use, the authors point to what is known as the “common liability” theory, which suggests that shared factors (such as age, education, socioeconomic status, or social context) predispose a person to try different substances, regardless of which came first.

“Rather than implying a causal gateway effect of cannabis use, the results highlight the importance of considering the broader life context in which substance use occurs,” the authors write.

At the same time, the study raises a rarely discussed but crucial issue: in contexts with severe prohibitionist laws like Japan’s, cannabis and other illegal drugs share the same distribution channels, increasing the user’s exposure to other substances, not because of the plant itself, but because of the illegality surrounding it.

In the report’s words: “It may be the regulatory environment, rather than the pharmacological properties of cannabis itself, that creates a ‘gateway’ effect.”

In addition, it comes as a surprise that this study originates from the Japanese government, one of the least tolerant countries when it comes to cannabis. Perhaps this type of initiative portends a hopeful change on the horizon?

What if cannabis were an exit drug?

This is not an isolated case. In North America, multiple recent studies indicate that cannabis not only does not encourage the use of other substances, but in some cases functions as a substitute for more dangerous or addictive drugs, helping people overcome problematic use.

In the US, for example, significant declines in alcohol and cigarette consumption among young people were recorded after cannabis legalization. Other research found reductions in the use of opioids, benzodiazepines, and alcohol among patients with legal access to medical cannabis.

Even the American Medical Association (AMA) has published studies linking long-term medical cannabis use to reduced pain and lower dependence on traditional painkillers.

One fact remains: despite the growing body of scientific data refuting the “gateway drug” myth, it continues to weigh heavily on public policies, institutional discourse, and fearmongering campaigns. The Japanese study -one of the largest and most representative conducted in Asia so far- demonstrates that it’s time to move away from assumptions and build our arguments on evidence.

Originally posted in El Planteo.



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading

featured

Adult-Use Cannabis Sales Launch in Delaware

Published

on


Adults aged 21 and older in Delaware can now purchase cannabis products from one of 12 licensed retail locations in the state, according to a 6ABC report.

Passed by lawmakers in 2023, the state’s adult-use law caps cannabis possession at one ounce of cannabis flower. Additionally, unlike in the medical program, retail cannabis purchases are taxed at a rate of 15%. Tax funds will be used to support schools, infrastructure, and public health systems in the state.

Earlier this week, Gov. Matt Meyer (D) toured a licensed cannabis cultivation facility alongside Marijuana Commissioner Josh Sanderlin to witness “how the state’s newest industry is preparing to open its doors,” the governor’s office said in a press release.

“The recreational cannabis market is a real opportunity to grow our economy, create good-paying jobs, and allow us to right previous wrongs in our communities. The students at Del Tech who are already training to work in this new industry are an indicator that the future is bright. We’re committed to doing this the right way — with strong safety standards, quality training, and product testing that ensures Delawareans have access to safe, reliable cannabis. Delaware will truly be the French wine of weed.” — Meyer, in a statement

“We are working closely with partners across the cannabis industry to build a framework that is both effective and responsible,” Sanderlin said.

Based in Portland, Oregon, Graham is Ganjapreneur’s Chief Editor. He has been writing about the legalization landscape since 2012 and has been contributing to Ganjapreneur since our official launch in…



Source link

mscannabiz.com
Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

Continue Reading
video38 minutes ago

Attorney General Mike Hilgers files lawsuit against Wyoming cannabis corporation

featured53 minutes ago

Senate Votes To Let VA Doctors Recommend Medical Marijuana To Military Veterans, While Setting Aside Hemp THC Ban

video2 hours ago

Kentucky’s first medical cannabis dispensary approved to open

featured2 hours ago

Japanese Study Busts the ‘Gateway Drug’ Myth, With Gov’t Support

video3 hours ago

New Haven smoke shop’s registration suspended after allegedly having illegal cannabis products

20253 hours ago

Star signs and cannabis strains: August 2025 horoscopes

featured3 hours ago

Adult-Use Cannabis Sales Launch in Delaware

video4 hours ago

North Carolina sets sights on legal cannabis, public input open

featured4 hours ago

Florida Marijuana Campaign Has Now Collected 75 Percent Of Signatures Needed To Put Legalization On 2026 Ballot

video5 hours ago

VIDEO | “A monumental occasion” – legal cannabis sales for recreational use begin | The Latest from WDEL News

featured5 hours ago

Cannabis Is Becoming the Ultimate Summer Vibe

featured6 hours ago

Michigan Signs Tribal Cannabis Compact With Bay Mills Indian Community

featured7 hours ago

Is Cannabis Really Legal If You Can’t Grow Your Own Weed?

video8 hours ago

Medical marijuana program to expand on Aug. 1

featured8 hours ago

Ganjapreneur Launches Paid Subscriptions for Cannabis Operators

video9 hours ago

Recreational marijuana sales begin in Delaware

featured9 hours ago

Trump Privately Committed To Reschedule Marijuana ‘Multiple Times’ Since Taking Office, CEO Says

video10 hours ago

Inside one of 12 locations that can now sell recreational marijuana in Delaware

featured10 hours ago

The Best Rum Drinks For Summer

featured11 hours ago

Curaleaf Opens 68th Florida Dispensary in St. Augustine

featured13 hours ago

New York Governor Seeks Lawmakers’ Help To Fix Marijuana Zoning Mishap That Could Shutter Over 100 Businesses

video13 hours ago

Delaware recreational marijuana sales set to begin at 12 locations around the First State

featured14 hours ago

The Cannabist Co. Celebrates Adult-Use Cannabis Sales Launch in Delaware

featured15 hours ago

MORE POT ON THE WAY FOR ’87 (1986)

Trending